TCL Archive Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing November 01, 2012Vol.38 No.41
TCL Archive Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer November 01, 2012Vol.38 No.41
TCL Archive Politicians Applaud CPRIT’s New Direction; UT Gives Waiver To MD Anderson’s DePinho October 26, 2012Vol.38 No.40
TCL Archive Ultrasound Shown to be Superior Diagnostic Compared to Mammography in Women Ages 30-39 October 26, 2012Vol.35 No.10
TCL Archive Conversation with The Cancer Letter: UT System Vice Chancellor Shine Describes Rationale for Granting Waiver to DePinho October 26, 2012Vol.38 No.40
TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012Vol.35 No.10
TCL Archive Komen Under Pressure: Charity Faces Money Woes, Attacks from Right October 26, 2012Vol.38 No.40
TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012Vol.35 No.10
